Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Robert Uzzo MD, MBA, FACS

Robert G. Uzzo MD, MBA, FACS

Deputy Chief Clinical Officer and Director, Surgical Services, Fox Chase Cancer Center/Jeanes Hospital; Chairman, Department of Surgical Oncology, Fox Chase Cancer Center; G. Willing “Wing” Pepper Professor of Urological Oncology, Fox Chase Cancer Center/Temple University; Chair, Fox Chase/Einstein Urologic Institute, Philadelphia, Pennsylvania

Dr. Uzzo graduated summa cum laude from Union College and attended Cornell University Medical College. He completed general surgical training followed by urologic surgical training at New York Hospital - Cornell Medical Center and Memorial Sloan-Kettering Cancer Center. He was an American Foundation for Urological Diseases Scholar in Urological Oncology and completed both Oncological and Renal Transplantation Fellowships at the Cleveland Clinic.

Dr. Uzzo is currently the Deputy Chief Clinical Officer; Director of Surgical Services, Fox Chase Cancer Center/Jeanes Hospital; Chairman of the Department of Surgical Oncology, Fox Chase Cancer Center; and the G. Willing “Wing” Pepper Professor of Urological Oncology at Fox Chase Cancer Center/Temple University. He is also the Chair of the Fox Chase/Einstein Urologic Institute. He maintains an active, funded laboratory investigating kidney and prostate cancer. His clinical interests include minimally invasive urological oncology and renal malignancies. He has authored over 300 peer-reviewed articles in urologic oncology. 

Recent Contributions to PracticeUpdate:

  1. Prevalence of Benign Pathologic Findings After Partial Nephrectomy With Preoperative Imaging Patterns
  2. Tumor–Parenchyma Interface and Long-Term Oncologic Outcomes After Robotic Tumor Enucleation for Sporadic RCC
  3. Clinical Complications in Renal Biopsy Using Two Different Needle Gauges
  4. Contemporary Surgical Management of Renal Oncocytoma
  5. Multiple Growth Periods Predict Unfavorable Pathology in Patients With Small Renal Masses
  6. Routine Renal Tumor Biopsy Is Associated With Lower Rates of Benign Histology on Resection for Small Renal Masses
  7. Perioperative Morbidity of Open Versus Minimally Invasive Partial Nephrectomy
  8. Comparison of Partial vs Radical Nephrectomy Effect on Other-Cause Mortality, Cancer-Specific Mortality, and 30-Day Mortality in Patients Older Than 75 Years
  9. Outcomes and Healthcare Costs of Robotic-Assisted vs Laparoscopic Radical Nephrectomy
  10. Cost Effectiveness in RCC—What Is Value and Who Gets to Decide?

Recently Updated